• Je něco špatně v tomto záznamu ?

Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin

Pavel Májek, Zuzana Reicheltová, Jana Stikarová, Jiří Suttnar, Alžběta Sobotková, Jan E Dyr

. 2010 ; 8 () : 56.

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20015370

Grantová podpora
NS10633 MZ0 CEP - Centrální evidence projektů

Background: Platelets are small anucleated blood particles that play a key role in the control of bleeding. Platelets need to be activated to perform their functions and participate in hemostasis. The process of activation is accompanied by vast protein reorganization and posttranslational modifications. The goal of this study was to identify changes in proteins in platelets activated by different agonists. Platelets were activated by three different agonists - arachidonic acid, collagen, and thrombin. 2D SDS-PAGE (pI 4-7) was used to separate platelet proteins. Proteomes of activated and resting platelets were compared with each other by Progenesis SameSpots statistical software; and proteins were identified by nanoLC-MS/MS. Results: 190 spots were found to be significantly different. Of these, 180 spots were successfully identified and correspond to 144 different proteins. Five proteins were found that had not previously been identified in platelets: protein CDV3 homolog, protein ETHE1, protein LZIC, FGFR1 oncogene partner 2, and guanine nucleotide-binding protein subunit beta-5. Using spot expression profile analysis, we found two proteins (WD repeat-containing protein 1 and mitochondrial glycerol-3-phosphate dehydrogenase) that may be part of thrombin specific activation or signal transduction pathway(s). Conclusions: Our results, characterizing the differences within proteins in both activated (by various agonists) and resting platelets, can thus contribute to the basic knowledge of platelets and to the understanding of the function and development of new antiplatelet drugs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20015370
003      
CZ-PrNML
005      
20241219145446.0
007      
ta
008      
200930s2010 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/1477-5956-8-56 $2 DOI
035    __
$a (PubMed)21073729
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Májek, Pavel $7 xx0128730 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
245    10
$a Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin / $c Pavel Májek, Zuzana Reicheltová, Jana Stikarová, Jiří Suttnar, Alžběta Sobotková, Jan E Dyr
520    9_
$a Background: Platelets are small anucleated blood particles that play a key role in the control of bleeding. Platelets need to be activated to perform their functions and participate in hemostasis. The process of activation is accompanied by vast protein reorganization and posttranslational modifications. The goal of this study was to identify changes in proteins in platelets activated by different agonists. Platelets were activated by three different agonists - arachidonic acid, collagen, and thrombin. 2D SDS-PAGE (pI 4-7) was used to separate platelet proteins. Proteomes of activated and resting platelets were compared with each other by Progenesis SameSpots statistical software; and proteins were identified by nanoLC-MS/MS. Results: 190 spots were found to be significantly different. Of these, 180 spots were successfully identified and correspond to 144 different proteins. Five proteins were found that had not previously been identified in platelets: protein CDV3 homolog, protein ETHE1, protein LZIC, FGFR1 oncogene partner 2, and guanine nucleotide-binding protein subunit beta-5. Using spot expression profile analysis, we found two proteins (WD repeat-containing protein 1 and mitochondrial glycerol-3-phosphate dehydrogenase) that may be part of thrombin specific activation or signal transduction pathway(s). Conclusions: Our results, characterizing the differences within proteins in both activated (by various agonists) and resting platelets, can thus contribute to the basic knowledge of platelets and to the understanding of the function and development of new antiplatelet drugs.
650    17
$a proteom $x agonisté $x analýza $2 czmesh $7 D020543
650    07
$a trombocyty $x fyziologie $2 czmesh $7 D001792
650    07
$a aktivace trombocytů $2 czmesh $7 D015539
650    07
$a hemostáza $2 czmesh $7 D006487
650    07
$a kyselina arachidonová $2 czmesh $7 D016718
650    07
$a kolagen $2 czmesh $7 D003094
650    07
$a thrombin $2 czmesh $7 D013917
650    07
$a lidé $2 czmesh $7 D006801
655    _7
$a práce podpořená grantem $2 czmesh $7 D013485
700    1_
$a Riedelová, Zuzana $7 xx0126185
700    1_
$a Štikarová, Jana $7 xx0127154
700    1_
$a Suttnar, Jiří, $d 1949- $7 xx0061396
700    1_
$a Hlaváčková, Alžběta $7 xx0122087
700    1_
$a Dyr, Jan Evangelista, $d 1946-2021 $7 xx0060262
773    0_
$t Proteome science $x 1477-5956 (elektronická verze) $g Roč. 8 (2010), s. 56 $w MED00008250
910    __
$a ABA008 $y 0 $z 0
990    __
$a 20200930104633 $b ABA008
991    __
$a 20241219145439 $b ABA008
999    __
$a kom $b bmc $g 1568154 $s 1105531
BAS    __
$a 3
BMC    __
$a 2010 $b 8 $d 56 $x MED00008250 $i 1477-5956 (elektronická verze) $m Proteome science
GRA    __
$a NS10633 $p MZ0
LZP    __
$c NLK120 $d 20241219 $a 2020-lp

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...